AT
BIIB icon

Arvest Trust’s Biogen BIIB Stock Holding History

Arvest Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$22.6M Buy
71,523
+466
+0.7% +$140K 2.09% 9
2014
Q1 		$20.4M Sell
71,057
-822
-1% -$261K 1.97% 9
2013
Q4 		$20.1M Sell
71,879
-1,744
-2% -$451K 1.99% 9
2013
Q3 		$17.7M Sell
73,623
-74,799
-50% -$16.7M 1.94% 11
2013
Q2 		$31.9M Buy
+148,422
New +$31.7M 3.66% 4

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Arvest Trust's BIIB Position: Q2 2014 in Review

Arvest Trust increased its Biogen (BIIB) stake by 0.66% in Q2 2014, buying an estimated $140K and bringing the position to 71,523 shares worth $22.6M. The position accounts for 2.09% of the portfolio, ranked #9.

Arvest Trust first reported a position in BIIB in Q2 2013 and has held it in 5 quarters since. The position peaked at $31.9M in Q2 2013. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Arvest Trust held 71,523 shares of Biogen worth $22.6M as of Q2 2014.
  • Arvest Trust bought 466 Biogen shares in Q2 2014, an estimated $140K.
  • Biogen made up 2.09% of Arvest Trust's portfolio in Q2 2014, its #9 holding.
  • Arvest Trust first reported a position in Biogen in Q2 2013 and has held it in 5 quarters since.
  • Arvest Trust's Biogen position peaked at $31.9M in Q2 2013.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Arvest Trust's 13F filing for Q2 2014, filed 14 Jul 2014.